California biotech company to open $50M facility in Union County.

PositionMycoWorks, Union, South Carolina

A California-based biotech company is opening its first facility in South Carolina in Union County.

MycoWorks, which creates luxury-quality leather alternatives using the trademarked Fine Mycelium, has selected Stream Realty Partners, CH Realty Partners, and Gray to help develop its first full-scale production facility in Union, S.C., according to a news release.

CH Realty Partners LLC, a Los Angeles-based developer in conjunction with Ascendant Capital Partners, a Los Angeles-based real estate investment firm will invest more than $50 million to expand and improve an existing warehouse at 260 Midway Drive in Union, South Carolina, the release stated. The facility, which MycoWorks will lease with a long-term commitment, will accommodate 135,000 square feet for the company's first full-scale Fine Mycelium production manufacturing facility

MycoWorks' new facility will offer approximately 50,000 square feet of manufacturing space, the release stated. It will include controlled environments for mixing, filling, and sterilization; work cells for tending the product as it grows; and areas for product harvesting and finishing.

Within the existing footprint, the facility will utilize approximately 40,000 square feet for an Automated Storage Retrieval System in a highly controlled environment that will house trays of the product as it grows into sheets, the release stated. A two-story expansion of 35,000 square feet for offices will be built adjacent to the existing warehouse. The remaining footprint will be used for storage, utilities, and maintenance areas.

Stream's National Program Management team will work with CH Realty Partners to manage all aspects of the delivery of the facility, from conceptual design through...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT